Sponsor pipeline

University of Florida clinical trial pipeline

Get alerts when University of Florida's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

24 trials changed in the last 30 days: 0 stopped, 10 with notable changes, 14 with minor changes only.

Show 14 trials with minor changes only
  1. Minor

    NavigateAKI · Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury

    Trial completed

    Also in this update: Final enrollment: 94 participants (planned 240); Primary completion date changed from estimate of Jun 2030 to Dec 1, 2025

    University of FloridaNot specified NCT02114138 Registry history of NCT02114138 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-15 NCT07875907 Repurposing Mefloquine for Pancreatic Cancer Treatment Phase 1 Not Yet Recruiting
2026-10-07 NCT07862400 A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia Phase 2 Not Yet Recruiting
2026-09-28 NCT07843264 PPI Dosing Per CYP2C19 Genotype Phase 4 Not Yet Recruiting

Active trials by phase

Early Phase 1
6
Phase 1
14
Phase 1/2
10
Phase 2
31
Phase 2/3
2
Phase 3
2
Phase 4
13
Not charted: 176 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 49

Get alerts when University of Florida's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free